Jimmy Holdings, Inc.'s Form 4 filing
Starling Oncology, Inc. (DFPH) · filed May 13, 2022
- Accession no.
- 0001437749-22-012393
- Filed
- May 13, 2022, 4:57 PM ET
- Trade date
- May 11, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $9.60M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Jimmy Holdings, Inc.CIK 0001892174 | 10% Owner |
| Agajanian RichyCIK 0001895577 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 11, 2022 | Class A Common Stock | SSaleDisposed | −1,346,565 | $6.00 | −$8,079,390 | 6,295,688 | Indirect | |
| May 11, 2022 | Class A Common Stock | SSaleDisposed | −253,435 | $6.00 | −$1,520,610 | 253,436 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.